Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity

Eur J Cancer. 2002 Sep;38(14):1832-7. doi: 10.1016/s0959-8049(02)00229-0.
No abstract available

Publication types

  • Review

MeSH terms

  • Amifostine / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Forecasting
  • Glutathione / therapeutic use
  • Growth Inhibitors / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I / therapeutic use
  • Interleukin-6*
  • Leukemia Inhibitory Factor
  • Lymphokines / therapeutic use
  • Nerve Growth Factor / drug effects
  • Nerve Growth Factor / therapeutic use
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / drug therapy
  • Radiation-Protective Agents / therapeutic use

Substances

  • Antineoplastic Agents
  • Growth Inhibitors
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Lymphokines
  • Radiation-Protective Agents
  • Insulin-Like Growth Factor I
  • Nerve Growth Factor
  • Glutathione
  • Amifostine